- Current report filing (8-K)
August 06 2009 - 8:58AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 5,
2009
|
|
RBC Life Sciences, Inc.
(Exact
name of registrant as specified in its charter)
|
|
NEVADA
(State
or other jurisdiction
of
incorporation)
|
000-50417
(Commission
File
Number)
|
91-2015186
(IRS
Employer
Identification
No.)
|
2301
CROWN COURT
,
IRVING
,
TEXAS
(Address
of principal executive offices)
|
75038
(Zip
Code)
|
Registrant's
telephone number, including area code
972-893-4000
|
|
N/A
(Former
name or former address, if changed since last
report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02 Results of
Operations and Financial Condition
.
On August
5, 2009, RBC Life Sciences, Inc. issued a press release announcing its financial
results for the quarter ended June 30, 2009. A copy of the press
release is being furnished as Exhibit 99.1 to this Form 8-K.
In
accordance with General Instruction B.2 of Form 8-K, this information, including
the exhibit related hereto, shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed
incorporated by reference in any disclosure document of the Company, except as
shall be expressly set forth by specific reference in such
document.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
release dated August 5, 2009 announcing financial results for the quarter
ended June 30, 2009.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: August
6, 2009
|
RBC
Life Sciences, Inc.
|
|
By:
/s/ Steven E.
Brown
Name:
Steven E. Brown
Title: Chief
Financial Officer
|
Exhibit
Index
Exhibit Number
|
Description
|
|
|
99.1
|
Press
release dated August 5, 2009 announcing financial results for the quarter
ended June 30, 2009
|
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From May 2024 to Jun 2024
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From Jun 2023 to Jun 2024